Preliminary Evidence for the Effects of Gentamicin on Vertical Semicircular Canals.

Abstract

Gentamicin is a vestibulotoxic antibiotic oft used in patients with Meniere's disease for its vestibular ablative effects. Gentamicin's effect on the horizontal semicircular canal does not always correlate with the degree of vertigo control achieved by patients; its effect on the vertical semicircular canals remains unknown. We sought to examine the effect of intratympanic gentamicin on vertical semicircular canal function in patients with Meniere's disease using video head impulse testing. A retrospective case series was carried out at a tertiary academic center. Patients with Meniere's disease who received >1 intratympanic gentamicin injection from 2019-2022 and had video head impulse testing performed were included. Outcomes of interest were vertical semicircular canal function following intratympanic gentamicin, and correlations between vertical semicircular canal function and horizontal semicircular canal function, and residual symptoms following injection. Ten patients met inclusion criteria. Twenty percent had abnormal V-SCC function prior to any injection, and 40% following the first injection. There was an association between abnormal vertical and horizontal semicircular canal function following the first intratympanic gentamicin injection, though the relationship did not reach statistical significance (p=0.058). While patients with abnormal vertical semicircular canal function following the first injection were less likely to report ongoing vertigo attacks, the relationship was not statistically significant (p=0.260). Intratympanic gentamicin leads to changes in vertical semicircular canal function in at least a proportion of patients with Meniere's disease. Further study is required to better assess correlations between vertical semicircular canal function and symptom control following intratympanic gentamicin.